In this issue:
The artificial sweetener erythritol and atherothrombotic disease risk
Acute health effects of coffee consumption
Does KDC score predict CV death and non-fatal CV events?
Heterogeneity in BP response to different antihypertensive drug classes
Patients’ and their physicians’ perspectives on oral anticoagulants for AF
Long-term outcomes according to LDL level achieved with evolocumab
Prevalence and prognostic significance of bradyarrhythmias in patients screened for AF
Effects of dapagliflozin according to duration of HF
Effects of SGLT2 inhibition on the risk of anthracycline-associated cardiotoxicity
The role of beta-blockers beyond one year post MI
Please login below to download this issue (PDF)